Keep in mind earnings are scheduled for Oct. 27 along with a $0.49 dividend on Sept. 30.
Can you please name me an industry that isn't impacted by this inflationary monster?
Let's see how this one plays out into Friday for a potential opportunity.
This action should help to set the stage for some good trading into third-quarter earnings.
BP slashed its dividend because of the pandemic, but the stock is still offering an attractive 5.3% dividend yield, with a solid payout ratio of only 40%.
First off, you need to do your fundamental homework.
The stock price may be cheap but it could get even cheaper.
While the big guns meet at the White House about the global chip shortage, the president and these companies are approaching this all wrong.
Costco Wholesale will report the firm's fiscal fourth quarter and full year financial performance Thursday evening.
Trading action seems to be shifting away from social media-driven names and into stocks with solid fundamentals and charts.
Let's check out the charts and indicators.
The chart of the trading platform operator shows impressive relative strength.
The market had a strange reaction to the initial headlines out of the Fed, and even now it's unclear how long the liquidity taps will remain open.
Jim Cramer said the 3D market is owned by Unity.
However, the lithium play is speculative, so traders would do well to recognize the risk before acting.
Investors are increasingly looking to the companies involved in clinical trials. Here are six favorite names in this space.
It was as if markets heard what they wanted to hear, when it was actually much more simple: markets heard exactly what they had anticipated.
Here we'll revisit Heartland Express after a slight dip -- and discover why it's probably even more valuable now.
Retests of the lows have been quite rare in recent years.
Let's dig into the market's mood this week and see what could happen if breadth continues to perform as it has been.
The setup on the weekly for the iShares 20+ Year Treasury Bond exchange-traded fund is a thing of beauty.
Let's sort out the FOMC meeting, what bonds are telling us and how this could all play out.
We will soon see if another V-shape move is in the cards.
In a market with elevated valuations and low yields, we see pharmaceutical stocks as a respite from both.
Let's look at the charts today and arrive at a trading strategy.
I believe this is one traders can opt to play for a longer-term move or a shorter-term look.
For the first time, the policy statement says that moderation of asset purchases 'may soon be warranted,' but it is expected that rate increases won't occur until the end of 2022.
And end you're obsession with the calendar.
Hop in or wait for another ride?
But aggressive action by retail traders is one reason that I'm not too worried about a substantial correction at this time.